1. Home
  2. AXTI vs STTK Comparison

AXTI vs STTK Comparison

Compare AXTI & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • STTK
  • Stock Information
  • Founded
  • AXTI 1986
  • STTK 2016
  • Country
  • AXTI United States
  • STTK United States
  • Employees
  • AXTI N/A
  • STTK N/A
  • Industry
  • AXTI Semiconductors
  • STTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • STTK Health Care
  • Exchange
  • AXTI Nasdaq
  • STTK Nasdaq
  • Market Cap
  • AXTI 94.4M
  • STTK 112.6M
  • IPO Year
  • AXTI 1998
  • STTK 2020
  • Fundamental
  • Price
  • AXTI $5.31
  • STTK $2.65
  • Analyst Decision
  • AXTI Strong Buy
  • STTK Hold
  • Analyst Count
  • AXTI 4
  • STTK 6
  • Target Price
  • AXTI $4.60
  • STTK $2.67
  • AVG Volume (30 Days)
  • AXTI 1.9M
  • STTK 411.6K
  • Earning Date
  • AXTI 10-30-2025
  • STTK 11-13-2025
  • Dividend Yield
  • AXTI N/A
  • STTK N/A
  • EPS Growth
  • AXTI N/A
  • STTK N/A
  • EPS
  • AXTI N/A
  • STTK N/A
  • Revenue
  • AXTI $86,080,000.00
  • STTK $2,997,000.00
  • Revenue This Year
  • AXTI N/A
  • STTK N/A
  • Revenue Next Year
  • AXTI $29.24
  • STTK N/A
  • P/E Ratio
  • AXTI N/A
  • STTK N/A
  • Revenue Growth
  • AXTI N/A
  • STTK N/A
  • 52 Week Low
  • AXTI $1.13
  • STTK $0.69
  • 52 Week High
  • AXTI $5.67
  • STTK $2.71
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 69.71
  • STTK 75.66
  • Support Level
  • AXTI $4.37
  • STTK $2.29
  • Resistance Level
  • AXTI $5.48
  • STTK $2.48
  • Average True Range (ATR)
  • AXTI 0.48
  • STTK 0.22
  • MACD
  • AXTI 0.03
  • STTK -0.01
  • Stochastic Oscillator
  • AXTI 80.83
  • STTK 100.00

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: